IL37 and cancer: It is worth mentioning that vvDD treatment also significantly increased IL-23R expression in the tumor at day 5 after treatment (Figure 3D) and in the vvDD-infected cancer cells in vitro (Figure 3G), supporting a rational combination of vvDD and cytokine IL-23.